Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-08

Clinical Trial Update: A Study to Test if TEV-53275 is Effective in Relieving Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial of TEV-53275 for asthma was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEV-53275

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2023-06-08